SCHEMBL7965198

SCHEMBL7965198

CSc1ccc(OC[C@@H](O)CN2CCC(O)(c3cnc4ccccc4c3)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.45
WDR77 Q9BQA1 1/20 0.45
ABCB1 P08183 7/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 3/20 0.42
TSHR P16473 2/20 0.42
GLA P06280 1/20 0.42
USP2 O75604 1/20 0.42
CYP2D6 P10635 1/20 0.42
HIF1A Q16665 1/20 0.42
ATM Q13315 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CHRNA7 P36544 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7953344 0.90 KDM4E (0.53) PRMT5WDR77ABCB1L3MBTL1SMN1; SMN2
SCHEMBL7966950 0.90 TSHR (0.56) PRMT5WDR77ABCB1L3MBTL1SMN1; SMN2
SCHEMBL7969553 0.89 L3MBTL1 (0.55) PRMT5WDR77ABCB1L3MBTL1SMN1; SMN2
SCHEMBL7966384 0.88 MAPT (0.53) PRMT5WDR77ABCB1L3MBTL1SMN1; SMN2
SCHEMBL7953572 0.88 KMT2A (0.54) PRMT5WDR77ABCB1L3MBTL1SMN1; SMN2
SCHEMBL7953454 0.88 PRMT5 (0.47) PRMT5WDR77ABCB1L3MBTL1SMN1; SMN2
SCHEMBL7965174 0.88 KMT2A (0.52) PRMT5WDR77ABCB1L3MBTL1SMN1; SMN2
SCHEMBL7969310 0.88 L3MBTL1 (0.51) PRMT5WDR77ABCB1L3MBTL1SMN1; SMN2
SCHEMBL7969773 0.88 ABCB1 (0.47) ABCB1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL7200720 0.88 SMN1; SMN2 (0.57) PRMT5WDR77ABCB1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed